AFib is becoming more common, with an estimated 12.1 million people in the United States expected to have the condition by 2030. This is due in part to an aging population and an increase in risk factors such as obesity and high blood pressure.

Advances in medical technology have made it easier to diagnose AFib, leading to more people being diagnosed with the condition. This includes the use of wearable devices and mobile health apps that can monitor heart rate and rhythm.

As more people are diagnosed with AFib, there is a growing awareness of the condition and its potential complications. This has led to increased efforts to prevent and manage AFib, including lifestyle changes and medication.

There are now more treatment options available for AFib, including medications, procedures such as ablation, and devices such as pacemakers. This has improved outcomes for people with the condition and reduced the risk of complications.

There is some evidence to suggest that COVID-19 may increase the risk of developing AFib, particularly in people with pre-existing heart conditions. This has led to increased interest in the condition and its management during the pandemic.

Dedicated to eliminating atrial fibrillation through education, support, and advocacy.

Global patient organization dedicated to providing information, support, and access to treatment for those affected by atrial fibrillation.

Cardiologist and advocate for patient-centered care, with a focus on arrhythmias like atrial fibrillation.

Neurosurgeon and medical correspondent who has covered atrial fibrillation and related topics extensively.

Cardiologist and author who specializes in arrhythmias, including atrial fibrillation.